Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?

Journal of Medical Ethics 47 (2):117-118 (2021)
  Copy   BIBTEX

Abstract

We thank Parker and Wright for engaging in this roundtable debate in such a spirited way. The ‘Pharmacogenetic [test] to Avoid Loss of Hearing’ Trial is the first time a genetic point of care test has been applied in the acute neonatal setting; therefore, it is not surprising that questions have been raised which require debate, discussion and clarification. Parker and Wright misattribute several assumptions to the roundtable authors, which we would like to clarify here. Since they raise wider questions about the PALOH trial itself, several of the roundtable discussants have made a joint response.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 76,391

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Great idea: what a fuss about a swab.Margot R. Brazier - 2020 - Journal of Medical Ethics 46 (8):534-535.
Moral Dilemmas in Modern Medicine.Michael Lockwood (ed.) - 1985 - Oxford University Press.
Dual loyalty in military medical ethics: a moral dilemma or a test of integrity?Peter Olsthoorn - 2019 - Journal of the Royal Army Medical Corps 165 (4):282-283.
Medical Error and Moral Luck.Dieneke Hubbeling - 2016 - HEC Forum 28 (3):229-243.
Biomarker Validation: Context and Complexities.Lisa M. McShane - 2019 - Journal of Law, Medicine and Ethics 47 (3):388-392.

Analytics

Added to PP
2020-12-24

Downloads
5 (#1,170,170)

6 months
1 (#451,971)

Historical graph of downloads
How can I increase my downloads?